However, misuse involving high-dose or oral administration and non-approved -agonists (e.g., clenbuterol) carries clear arrhythmic and ischemic risk
This article will explore the similarities and differences between two drugs that can help manage weight: Mounjaro and Wegovy
It may enhance the effects of warfarin and other blood thinners, potentially increasing bleeding risk
Finally, a statistical analysis of the people in the atherosclerosis study who lost weight during the several-year study and follow-up period found a meaningful association between metformin use, lac-phe production and weight loss
Wegovy: Specifically approved for chronic weight management in adults with a BMI of 30 kg/m, or 27 kg/m with weight-related medical diseases/conditions
Most gastrointestinal events were mild to moderate and of relatively short duration (median duration of events: nausea [5 days in both groups], vomiting [2 days in both groups], diarrhea [3 days in both groups], and constipation [27 days with semaglutide vs 16 days with placebo]), and the majority of participants recovered without treatment discontinuation (eFigure 8 in Supplement 1)